605266 Stock Overview
Jianzhijia Pharmaceutical Chain Group Co., Ltd. More details
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 3/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥26.34 |
| 52 Week High | CN¥52.81 |
| 52 Week Low | CN¥17.18 |
| Beta | 0.96 |
| 11 Month Change | 18.38% |
| 3 Month Change | 43.23% |
| 1 Year Change | -46.88% |
| 33 Year Change | -29.58% |
| 5 Year Change | n/a |
| Change since IPO | -38.36% |
Recent News & Updates
Recent updates
Shareholder Returns
| 605266 | CN Consumer Retailing | CN Market | |
|---|---|---|---|
| 7D | -0.08% | -0.2% | -0.6% |
| 1Y | -46.9% | -14.2% | 3.2% |
Return vs Industry: 605266 underperformed the CN Consumer Retailing industry which returned -14.2% over the past year.
Return vs Market: 605266 underperformed the CN Market which returned 3.2% over the past year.
Price Volatility
| 605266 volatility | |
|---|---|
| 605266 Average Weekly Movement | 10.7% |
| Consumer Retailing Industry Average Movement | 7.9% |
| Market Average Movement | 8.4% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 605266's share price has been volatile over the past 3 months compared to the CN market.
Volatility Over Time: 605266's weekly volatility (11%) has been stable over the past year, but is still higher than 75% of CN stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1998 | 21,000 | Bo Lan | www.jzj.cn |
Jianzhijia Pharmaceutical Chain Group Co., Ltd. engages in the pharmaceutical retail business in China. The company operates direct operated stores, as well as an online pharmacy business.
Jianzhijia Pharmaceutical Chain Group Co., Ltd. Fundamentals Summary
| 605266 fundamental statistics | |
|---|---|
| Market cap | CN¥4.13b |
| Earnings (TTM) | CN¥236.80m |
| Revenue (TTM) | CN¥9.32b |
17.4x
P/E Ratio0.4x
P/S RatioIs 605266 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 605266 income statement (TTM) | |
|---|---|
| Revenue | CN¥9.32b |
| Cost of Revenue | CN¥5.97b |
| Gross Profit | CN¥3.34b |
| Other Expenses | CN¥3.10b |
| Earnings | CN¥236.80m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.51 |
| Gross Margin | 35.87% |
| Net Profit Margin | 2.54% |
| Debt/Equity Ratio | 118.0% |
How did 605266 perform over the long term?
See historical performance and comparison